Starr Ventures

Portfolio · 1

NeoTX

Immuno-oncology Drug Development

2 rounds $18.0M committed Latest: 2017-12

Investment activity

Q&A

What is Starr Ventures' primary investment focus by sector?

Starr Ventures primarily focuses on the Health Tech & Life Sciences sector, with all of its known portfolio companies and investment rounds concentrated in this area.

Can you name a notable company in Starr Ventures' portfolio?

A notable company in Starr Ventures' portfolio is NeoTX, which is involved in immuno-oncology drug development.

What stage investments does Starr Ventures typically make?

Starr Ventures has participated in both Series A and Series B funding rounds, indicating an interest in early to growth-stage companies.

When did Starr Ventures make its most recent recorded investment?

Starr Ventures' most recent recorded investment activity was in December 2017.

What was the funding stage and amount for NeoTX, a Starr Ventures portfolio company?

NeoTX, a Starr Ventures portfolio company, raised a Series C round totaling $65.5 million.

What is the typical investment range for Starr Ventures?

Starr Ventures' investment range is typically between $8.8 million and $9.2 million.